#LiverHealth Archives

Immune Dysfunction and Infection Risk in Advanced Liver Disease

By Mourabit Halima 2025.02.17

The latest review in Gastroenterology explores the complex relationship between immune dysfunction and infection risk in advanced liver disease, highlighting the contributions of Brett McGettigan, Maria Hernandez-Tejero, Harmeet Malhi, and…

Advancing Liver Cancer Care: Join the EASL Liver Cancer Summit 2025 in Paris

By Mourabit Halima 2025.02.17

The EASL Liver Cancer Summit 2025 will take place in Paris from February 20-22, bringing together leading experts to discuss the latest developments in liver cancer diagnosis, prognosis, and treatment.…

Expert Interview with Dr. Jiajie Liao: Optimizing Cost-Effective Strategies for Hepatitis B Treatment

By Mourabit Halima 2025.01.06

Recently, the American Association for the Study of Liver Diseases (AASLD 2024) was held in San Diego, USA. The prestigious event brought together leading experts and scholars in the field…

Expert Interview with Dr. Jun Li: New Insights into Hepatitis B-Related ACLF Research

By Lisa Cui 2025.01.02

Acute-on-Chronic Liver Failure (ACLF) is one of the most severe and life-threatening liver diseases in China and the Asia-Pacific region. This complex condition arises from multiple factors, with host genetic…

AASLD Exclusive Interview with Dr. Grace Lai-Hung Wong: Quantitative HBsAg – A New Perspective in Advancing Hepatitis B Management and Functional Cure

By Peng Longmei 2024.12.27

With significant progress in hepatitis B treatment, particularly in the pursuit of a functional cure, the quantification of hepatitis B surface antigen (HBsAg) has emerged as a critical factor in…

AASLD Exclusive Interview with Dr. Vincent Wai-Sun Wong: Challenges and Frontiers in Managing MASLD in Asia

By Lisa Cui 2024.12.26

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) continues to rise globally, driven by the increasing rates of obesity and metabolic syndrome. Epidemiological studies indicate that by 2019, the…

AASLD 2024丨Dr. Hong You and Dr. Aiting Yang ‘s Team Unveils the Critical Role of ECM1-Expressing HSC Subpopulations in Liver Fibrosis Reversal

By El Bachir MOURABIT 2024.12.05

Recent advancements in single-cell transcriptomics have uncovered the significant heterogeneity of hepatic stellate cells (HSCs), highlighting the unique gene expression profiles and functions of different HSC subpopulations. At the 2024…

AASLD Featured New Voices | Terry Yip and Jimmy Lai Explore the New Progress of Liver Disease

By Mourabit Halima 2024.12.05

Editor's note: At the recent AASLD 2024, the annual meeting of the American Association for the Study of Liver Diseases, top experts from the global liver disease field gathered to…

Dr.Hong You and Dr.Wei Chen’s Team Proliferative T Cell Subpopulations in the Liver Promote Fibrosis Reversal in CHB Patients After Antiviral Therapy

By Qingyuan Liu 2024.12.03

Chronic Hepatitis B (CHB) is a prevalent chronic inflammatory liver disease in China, often resulting in sustained hepatic parenchymal damage, liver fibrosis, and adverse outcomes such as cirrhosis, liver failure,…

AASLD 2024丨Dr. Jinlin Hou’s Team: Cost-Effectiveness of aMAP Score-Guided Individualized HCC Screening in HBsAg-Positive Populations

By Lisa Cui 2024.12.02

The 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) took place in San Diego, USA, from November 15 to 19, 2024. Six research projects…